球部尿道狭窄颊黏膜移植尿道成形术后的患者报告结局:前瞻性单中心队列研究
该前瞻性单中心队列研究纳入97例因球部尿道狭窄行颊黏膜移植尿道成形术的患者,术前及术后三次随访(中位2.1、7.8、17.0个月)完成IPSS、IPSS-QOL、UDI-6、IIEF-5及ICIQ-LUTS-QOL等问卷。术后排尿症状和生活质量显著改善并维持,基线勃起功能良好者术后首次随访IIEF-5显著下降但后续完全恢复;治疗失败率9.3%。
要点
- 颊黏膜移植尿道成形术后排尿症状及生活质量显著持续改善。
- 基线勃起功能良好者术后早期IIEF-5下降,但随访期间完全恢复。
- 治疗失败率9.3%,成功不应仅以无狭窄复发定义。
核心结论
- 术后排尿症状和生活质量显著改善,基线勃起功能良好者随访期间勃起功能恢复。
- 研究强调PROMs在尿道重建手术中的重要性,成功不应仅由无狭窄生存定义。
研究设计与样本
- 前瞻性单中心队列研究,纳入2009年10月至2017年2月行颊黏膜移植尿道成形术的球部尿道狭窄患者97例。
- 术前及术后第一次、第二次、第三次随访时完成五份PROM问卷,并评估Qmax、残余尿量和总排尿量。
主要发现
- IPSS、IPSS-QOL、UDI-6和ICIQ-LUTS-QOL评分在第一次随访时较基线显著改善并持续(P ≤ 0.001)。
- 基线无或轻度勃起功能障碍者第一次随访IIEF-5中位数从23.0(IQR 21.0-25.0)降至19.5(IQR 16.0-23.8),P ≤ 0.001;第三次随访恢复至24.0(IQR 20.5-25.0),P = 0.86。
- 勃起和射精功能中位数无显著变化;第一次随访VAS中位数3.0(IQR 2.0-4.45),第三次随访降至0.0(IQR 0.0-1.0),P ≤ 0.001。
- 9例(9/97,9.3%)治疗失败;按术前术后Qmax差值<10 mL/s vs ≥10 mL/s分层复发无显著差异(P = 0.06)。
临床怎么用
- 应重视颊黏膜移植尿道成形术后的患者报告结局,包括排尿症状、生活质量、性功能和口腔疼痛。
- 术后早期勃起功能可能下降,应告知基线勃起功能良好者该下降多在随访中恢复。
局限性
- 单中心前瞻性队列,样本量97例,随访至第三次时仅70例完成。
- 未设对照组,治疗失败定义包含任何需尿流改道或尿道器械操作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe patient-reported outcome measures (PROMs) after buccal mucosa graft (BMG) urethroplasty. MATERIALS AND METHODS: We prospectively collected PROMs in patients who underwent BMG urethroplasty for bulbar urethral strictures between October 2009 and February 2017. Preoperatively and at the first, second and third postoperative follow-up visits, patients completed five PROM questionnaires: the International Prostate Symptom Score (IPSS); the IPSS Quality of Life questionnaire; the Urogenital Distress Inventory Short-Form questionnaire (UDI-6); the International Index of Erectile Function (IIEF)-5 questionnaire, combined with IIEF-Q9 and IIEF-Q10 for assessing ejaculatory and orgasmic functions; and the International Consultation on Incontinence Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTS-QOL) questionnaire. In addition to using these questionnaires, we evaluated maximum urinary flow rate (Qmax ), post-void residual urine volume and total voided urine volume at each follow-up visit. Buccal pain and discomfort were assessed using a visual analogue scale (VAS). Comparison of questionnaire scores was performed using a paired Wilcoxon rank-sum test. Treatment failure was defined as any need for urinary diversion or urethral instrumentation after surgery. RESULTS: A total of 97 patients met the inclusion criteria. The first postoperative follow-up visit was at a median of 2.1 months (n = 97/97), and the second and third visits were after a median of 7.8 (n = 82/97) and 17.0 months (n = 70/97), respectively. Significant improvements compared to baseline were observed in IPSS, and IPSS-QOL, UDI-6 and ICIQ-LUTS-QOL scores at the first follow-up, and remained improved during the follow-up period (P ≤ 0.001). Patients with mild to no baseline erectile dysfunction experienced a significant decline in erectile function at the first follow-up (median [interquartile range {IQR}] preoperative IIEF-5 score 23.0 [21.0-25.0] vs median [IQR] IIEF-5 score at first follow-up 19.5 [16.0-23.8]; P ≤ 0.001). This decline fully recovered during further follow-up (median [IQR] IIEF-5 score at third follow-up 24.0 [20.5-25.0]; P = 0.86). No significant changes in median orgasmic and ejaculatory function were noted. The first postoperative median (IQR) VAS score was 3.0 (2.0-4.45), and a significant improvement in local pain and discomfort was observed during the follow-up (median [IQR] VAS at third follow-up: 0.0 [0.0-1.0]; P ≤ 0.001). Nine patients (9/97; 9.3%) had treatment failure. Stratifying recurrence based on a difference of <10 mL/s vs ≥10 mL/s between preoperative and postoperative Qmax could not demonstrate a significant difference (P = 0.06). CONCLUSION: Significant improvements in voiding symptoms and quality of life after surgery were reported. Patients with good baseline erections recovered erectile function during follow-up, although a significant decrease in erectile function was observed at the first follow-up. This study highlights the importance of PROMs in urethral reconstructive surgery, emphasizing that success should not be defined only by stricture-free survival.
引用
- D'hulst P, Muilwijk T, Vander Eeckt K, et al. Patient-reported outcomes after buccal mucosal graft urethroplasty for bulbar urethral strictures: results of a prospective single-centre cohort study. BJU Int. 2020. PMID: 32512634. doi:10.1111/bju.15131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。